CytomX Therapeutics, Inc.（CTMX）内部人交易：高管与董事近期交易
过去 18 个月，共有 6 位内部人为 CytomX Therapeutics, Inc.（CTMX）报告了 19 笔 Form 4 交易（最近一笔 2026-08-05）。
| 日期 | 内部人 | 职务 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-08-05 | Carvajal Alejandra | Chief Legal Officer | 买入 | 100,000 | $0 |
| 2026-06-17 | Ogden Christopher | Chief Financial Officer | 卖出 | 1,624 | $4,953 |
| 2026-03-19 | McCarthy Sean A. | CEO | 卖出 | 118,969 | $763,781 |
| 2026-03-19 | BELVIN MARCIA | SVP, Chief Scientific Officer | 卖出 | 31,492 | $202,179 |
| 2026-03-19 | Chu Yu-Waye | Chief Medical Officer | 卖出 | 21,279 | $136,611 |
| 2026-03-19 | Ogden Christopher | Chief Financial Officer | 卖出 | 19,323 | $124,054 |
| 2026-02-04 | BELVIN MARCIA | SVP, Chief Scientific Officer | 买入 | 60,000 | $0 |
| 2026-02-04 | Chu Yu-Waye | Chief Medical Officer | 买入 | 75,000 | $0 |
| 2026-02-04 | McCarthy Sean A. | CEO | 买入 | 210,000 | $0 |
| 2026-02-04 | Ogden Christopher | Chief Financial Officer | 买入 | 90,000 | $0 |
| 2026-02-04 | Lester Rachael | Chief Business Officer | 买入 | 20,000 | $0 |
| 2025-11-10 | McCarthy Sean A. | CEO | 卖出 | 101,793 | $462,140 |
| 2025-06-17 | BELVIN MARCIA | SVP, Chief Scientific Officer | 买入 | 37,500 | $0 |
| 2025-06-17 | BELVIN MARCIA | SVP, Chief Scientific Officer | 卖出 | 13,884 | $37,348 |
| 2025-06-17 | Ogden Christopher | Chief Financial Officer | 卖出 | 1,641 | $4,841 |
| 2025-06-17 | Ogden Christopher | Chief Financial Officer | 买入 | 37,500 | $0 |
| 2025-06-17 | Ogden Christopher | Chief Financial Officer | 卖出 | 10,614 | $28,552 |
| 2025-06-17 | McCarthy Sean A. | CEO | 买入 | 150,000 | $0 |
| 2025-06-17 | McCarthy Sean A. | CEO | 卖出 | 55,511 | $149,325 |
来源：SEC Form 4 申报文件 · 截至 2026-08-05